Donald Trump’s choice to run the Department of Health and Human Services spooked investors who worry what Kennedy would do.
Category: Vaccination and Immunization
-
New York Times Takes European Commission to Court Over Covid Vaccine Deal
The news outlet is pushing the Commission to release text messages between the E.U.’s top official and Pfizer as they negotiated a vaccine contract.
-
Why Businesses Worry About R.F.K. Jr.
The Kennedy scion has long been a skeptic of vaccines, pesticides and more. Corporate leaders worry he may gain policy power if Donald Trump wins.
-
Nasal Flu Vaccine Is Approved for At-Home Use
The F.D.A. authorized AstraZeneca’s treatment to be given outside a health care setting, although it will still need a prescription.
-
Covid Normalcy: No Tests, Isolation or Masks
For many, Covid is increasingly regarded like the common cold. A scratchy throat and canceled plans bring a bewildering new critique from friends: You shouldn’t have tested.
-
What to Know About Masks and Covid During Late Summer Travel
With U.S. Covid-19 cases at very high levels and new vaccines still several weeks away, we asked experts for their advice on when and where to wear a mask.
-
E.U. Court Rebukes European Commission Over Covid Vaccine Contracts
The court ruled that the European Commission wrongly withheld information, casting a shadow on its leader, Ursula von der Leyen, before a crucial vote on her future.
-
Malaria Vaccine Rollout to Africa Is a Cautionary Tale
After years of delay, millions of malaria vaccines are being supplied to children in Africa. Tens of thousands died waiting.
-
You Tested Positive for Covid. Can You Still Travel?
With coronavirus cases on the rise, summer travelers are once again facing difficult questions. Here’s the latest travel guidance from health experts.
-
A Bird-Flu Pandemic in People? Here’s What It Might Look Like.
There is no guarantee that a person-to-person virus would be benign, scientists say, and vaccines and treatments at hand may not be sufficient.
-
New Covid Vaccine Endorsed for Fall
The panel endorsed targeting a variant of the coronavirus that is now receding, though some officials suggested aiming at newer versions of the virus that have emerged in recent weeks.